AVAH Aveanna Healthcare Holdings, Inc.

Nasdaq Services-Home Health Care Services DE CIK: 0001832332
AI RATING
SELL
68% Confidence

Investment Thesis

While Aveanna demonstrates strong revenue growth (+20.2% YoY) and improving operating margins, the company exhibits significant financial stress: negative free cash flow (-$4.5M) despite net income of $41.7M indicates earnings quality concerns, and extreme leverage (5.40x Debt/Equity) with weak interest coverage (2.4x) creates refinancing risk. The disconnect between reported profitability and actual cash generation in a capital-intensive business is unsustainable.

Strengths

  • + Strong revenue growth at 20.2% YoY ($647.9M total revenue)
  • + Improving profitability with gross margin of 31.7% and operating margin of 10.7%
  • + Adequate liquidity with $189.3M in cash and 1.47x current ratio
  • + Solid ROE of 17.4% demonstrates reasonable returns on shareholder capital

Risks

  • ! Negative free cash flow (-$4.5M) despite positive net income - major earnings quality concern
  • ! Severe leverage at 5.40x Debt/Equity with only 2.4x interest coverage - refinancing risk
  • ! Operating cash flow of only $4.3M represents just 10% of net income - suggests non-cash gains or working capital distress
  • ! Capital expenditure of $8.8M exceeds operating cash flow - unsustainable cash burn in capital-intensive business

Key Metrics to Watch

Financial Metrics

Revenue
647.9M
Net Income
41.7M
EPS (Diluted)
$0.19
Free Cash Flow
-4.5M
Total Assets
2.0B
Cash
189.3M

Profitability Ratios

Gross Margin 31.7%
Operating Margin 10.7%
Net Margin 6.4%
ROE 17.4%
ROA 2.1%
FCF Margin -0.7%

Balance Sheet & Liquidity

Current Ratio
1.47x
Quick Ratio
1.47x
Debt/Equity
5.40x
Debt/Assets
88.1%
Interest Coverage
2.38x
Long-term Debt
1.3B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-16T08:40:01.933715 | Data as of: 2026-04-04 | Powered by Claude AI